| Stephanie Nicole Libes, CRNP | |
|
130 S Bryn Mawr Ave, Bryn Mawr, PA 19010-3121 | |
| (215) 662-3743 | |
| (215) 349-5895 |
| Full Name | Stephanie Nicole Libes |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 130 S Bryn Mawr Ave, Bryn Mawr, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1023661352 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | SP020270 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Presbyterian Medical Center | Philadelphia, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Pennsylvania Hospital | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Penn - Medical Group | 6204730955 | 3031 |
News Archive
The prevalence of frailty, which is linked to earlier death, increases throughout adulthood as people age and not just after age 65, found an article in CMAJ (Canadian Medical Association Journal). Relatively good fitness levels at all ages were predictive of lower mortality and less reliance on health care services.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
Creating and promoting foods that contain natural inhibitors of unhealthy angiogenesis - the formation of blood vessels that feed and promote disease, obesity and inflammation - is the "new frontier in dietary health," according to a presentation at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- in Chicago.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
› Verified 1 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235527342 PECOS PAC ID: 6204730955 Enrollment ID: O20141111000091 |
News Archive
The prevalence of frailty, which is linked to earlier death, increases throughout adulthood as people age and not just after age 65, found an article in CMAJ (Canadian Medical Association Journal). Relatively good fitness levels at all ages were predictive of lower mortality and less reliance on health care services.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
Creating and promoting foods that contain natural inhibitors of unhealthy angiogenesis - the formation of blood vessels that feed and promote disease, obesity and inflammation - is the "new frontier in dietary health," according to a presentation at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- in Chicago.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
› Verified 1 days ago
| Entity Name | University Of Penn - Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053447151 PECOS PAC ID: 6204730955 Enrollment ID: O20150304001436 |
News Archive
The prevalence of frailty, which is linked to earlier death, increases throughout adulthood as people age and not just after age 65, found an article in CMAJ (Canadian Medical Association Journal). Relatively good fitness levels at all ages were predictive of lower mortality and less reliance on health care services.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
Creating and promoting foods that contain natural inhibitors of unhealthy angiogenesis - the formation of blood vessels that feed and promote disease, obesity and inflammation - is the "new frontier in dietary health," according to a presentation at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- in Chicago.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Stephanie Nicole Libes, CRNP 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010-3121 Ph: (215) 662-3743 | Stephanie Nicole Libes, CRNP 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010-3121 Ph: (215) 662-3743 |
News Archive
The prevalence of frailty, which is linked to earlier death, increases throughout adulthood as people age and not just after age 65, found an article in CMAJ (Canadian Medical Association Journal). Relatively good fitness levels at all ages were predictive of lower mortality and less reliance on health care services.
Measuring levels of transforming growth factor-α and interleukin-6 may help identify patients with newly diagnosed chronic phase-chronic myeloid leukaemia at risk of a poor outcome from tyrosine kinase inhibitor therapy, research suggests.
Creating and promoting foods that contain natural inhibitors of unhealthy angiogenesis - the formation of blood vessels that feed and promote disease, obesity and inflammation - is the "new frontier in dietary health," according to a presentation at the 2013 Institute of Food Technologists Annual Meeting & Food Expo- in Chicago.
OncoGenex Pharmaceuticals, Inc. announced today that Borealis-2, an investigator-sponsored, randomized Phase 2 trial, has met its target enrollment of 200 patients. Designed to evaluate apatorsen in combination with docetaxel in patients with advanced or metastatic bladder cancer who have disease progression following first-line platinum-based chemotherapy, Borealis-2 is sponsored by Hoosier Oncology Group and is being conducted at 27 sites across the United States.
› Verified 1 days ago
Mrs. Jodi Lynn Kanzinger, NP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 S Bryn Mawr Ave, Suite H321, Bryn Mawr, PA 19010 Phone: 484-337-4097 Fax: 484-337-4086 | |
Harriet Marie Mccarney, CRNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1030 E Lancaster Ave, Bryn Mawr, PA 19010 Phone: 610-525-3225 Fax: 610-525-4932 | |
Jenna Walck, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr, PA 19010 Phone: 484-337-3000 | |
Ms. Meghan R. Skakun, APN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 130 S Bryn Mawr Ave, Bryn Mawr Hospital, Bryn Mawr, PA 19010 Phone: 484-337-4618 Fax: 484-337-4661 | |
Awilda Rodriguez, Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 830 Old Lancaster Rd Ste 206, Bryn Mawr, PA 19010 Phone: 484-380-3094 | |
Rachel Melissa Goldstein, CRNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 918 County Line Rd, Bryn Mawr, PA 19010 Phone: 610-525-6086 |